key: cord-0972367-vte52lah authors: Wicaksana, Anggi Lukman; Hertanti, Nuzul Sri; Ferdiana, Astri; Pramono, Raden Bowo title: Diabetes management and specific considerations for patients with diabetes during coronavirus diseases pandemic: A scoping review date: 2020-07-04 journal: Diabetes Metab Syndr DOI: 10.1016/j.dsx.2020.06.070 sha: 949cc3b2246bf3357babdb9c68cc77d4c6e69afe doc_id: 972367 cord_uid: vte52lah BACKGROUND AND AIMS: The global pandemic of coronavirus (COVID-19) affects almost all countries in the world, which potentially alter diabetes management. Many diabetes patients are experiencing barrier of care due to the policy related to COVID-19. This article aims to review the current evidence on diabetes management and specific consideration during the COVID-19 pandemic for people living with diabetes. METHODS: We conducted a scoping review in PubMed, Science Direct, DOAJ and Microsoft Academics databases from January 1 to April 17, 2020. Searching terms included “COVID-19", “severe acute respiratory syndrome coronavirus 2", and “Diabetes Mellitus” were used. Only scientific articles discussing diabetes management and specific considerations were selected and extracted. RESULTS: A total of 7 articles was selected in the analysis. Most were published in diabetes journals (85.71%). All articles (100%) discussed diabetes management and 71.43% of them provided diabetes care in specific considerations. We discussed issue of diabetes management in glycemic control and monitoring, dietary intake, physical activity, medication, education and prevention of COVID-19 infection that applicable for diabetes patients. In addition, specific considerations explored caring for diabetes in children and adolescents, pregnancy, elderly, emergency or critical care, to offer certain concern for raising the awareness. CONCLUSIONS: This review specifies a summary of diabetes management as well as the particular considerations to care people living with diabetes during COVID-19 pandemic. Patients, health care providers, and policy makers could take advantage of the review to assist diabetic people passing through COVID-19 pandemic session with optimum glycemic outcome. diabetic people passing through COVID-19 pandemic session with optimum glycemic outcome. KEYWORDS: COVID-19, diabetes, diabetes management, pandemic, scoping review, special consideration The rapid spreading of COVID-19 globally has extensively brought many consequences on care particularly for patients who have comorbid conditions [1, 2] . Diabetes ranked second as the most prevalent comorbidities (9.7%, 95% CI 6.9-12.5%) among COVID-19 patients after cardio-metabolic diseases [1, 3, 4] . People living with diabetes are at higher risk of having COVID-19 infection and potentially experiencing more severe illness when infected [4, 5] . A meta-analysis from China reported that COVID-19 patients with diabetes had twice the risk of intensive care unit (ICU) admission [6] and it makes diabetes as independent predictor of ICU admission or invasive mechanical ventilation in COVID-19 patients [3, 7] . A recent systematic review also identified that COVID-19 patients with diabetes is related to an increased risk of ICU admission (OR: 2.79, 95% CI 1.85-4.22, I 2 = 46%, for review. Non-scientific publication, correspondences, news and commentary were excluded. The outcome of two independent searches was compared. Difference finding were communicated and discussed until the same numbers of articles were reported. Duplicated articles were removed. Excel spreadsheet was used to short-list the articles during selection procedure. Seven articles were included for review after screening and checking eligibility. The preferred reporting item for systematic review and meta-analysis (PRISMA) was used as guidance in reporting the searching process ( Fig. 1 ) [10] . Included articles were compiled and extracted in an Excel worksheet. The extracted data included title, authors and date of publication, country and region, research objective, study design, target of study, sample size, study setting, data collection, key findings, research domains and subdomains. All the included articles were categorized into two domains i.e. diabetes management and specific consideration. Diabetes management refers to all actions to treat, manage and cope with disease process of diabetes. Specific consideration concerns on such particular situation that requires thoughtfulness of care. Diabetes management domain was further classified into six sub-domains i.e. glycemic control and monitoring, dietary intake, physical activity, medication, education, and prevention. Specific consideration was classified into sub-domains of diabetes in children and adolescents, pregnancy, older people, and emergency or critical care. Methodological characteristics of the articles were also evaluated using Excel spreadsheet. Each article will be assessed about the study design, target of study, sample size, and setting. Then, the data were classified and presented in the percentage. Most articles were published in journal of diabetes and metabolic diseases (85.71%, n = 6) followed by medical virology journal (14.29%, n = 1). The majority of articles were from Asian region (57.14%, n = 4) followed by European and American region (28.57%, n = 2; 14.29%, n = 1, respectively). All articles discussed diabetes management domain and only 71.43% provided information for specific consideration domain. Fig. 2 shows the subdomains identified in the articles. Most articles focused on medication (71.43%) and only 1 article (14.29%) discussed about COVID-19 preventive action for diabetes patients. In terms of specific consideration domain, most articles focused on emergency or critical care (42.86%). Most articles used review or unclear study design (42.86%, n = 3 for both). The majority of study targets were patients (57.14%, n = 4) and located in hospital and community setting (57.14%, n = 4). Most included studies did not reported sample size (71.43%, n = 5, Table 1 ). Information of data extraction is available in Table 2 . All included articles covered research domains and subdomains through presenting main findings. Although some included Running head: Diabetes during coronavirus pandemic 6 articles did not provide detail information of study design, sample size, and data collection; the articles were analyzed and presented since it covered the research aims. According to The American Diabetes Association standard of diabetes care for patients and health care workers, diabetes care should includes comprehensive medical assessment of comorbidities, lifestyle management, glycemic control, medication, obesity management, risk reduction, and prevention of diabetes complication [14] [15] [16] . Diabetes management will be discussed according to these standards of care: glycemic control and monitoring, dietary intake, physical activity, medication, education, and prevention of COVID-19 infection in the context of COVID-19 pandemic. All diabetic patients must maintain glycemic control and monitoring during the pandemic. Patients with diabetes could potentially find difficulties for glycemic control and monitoring during the lockdown or quarantine. They could have problem on getting an access to medicine and glycemic monitoring materials, including glucose strips, glucometers, and needles. Thus, it is recommended for diabetic patients to early purchase the glycemic monitoring materials and medicine through online [2, 7, 8] . A tailored glycemic monitoring for diabetic patients could be adjusted by considering age, existing comorbidity, clinical manifestation, and other risk factors [8] . Glycemic monitoring using capillary blood test is acceptable for people living with diabetes during pandemic [2, 7] . All hospitalized COVID-19 patients with diabetes should undergo closed glycemic control and routine blood glucose monitoring. Previous research indicated that COVID-19 patients with diabetes were associated with the poor outcomes of health [3, 7] . When they are discharged, blood glucose monitoring is highly recommended amid a 4-week follow up after discharge and they have to avoid exposure to infection [8] . Timing for glycemic control and monitoring can be adjusted for particular occasion. During pandemic, fasting and postprandial blood glucose in diabetes patients who consume oral anti diabetic agent(s) with tolerable outcomes (i.e. stable blood glucose record or fasting blood glucose less than 125 mg/dl or HbA1c less than or equal to 6.5%) could be performed once or twice a week. Meanwhile, for diabetes patients who administer insulin with poor outcomes or intermittent hypoglycemia, blood glucose should be checked at least four times a day i.e. fasting, pre lunch, pre dinner and bedtime. Any sign or symptom of occurring hypoglycemia is reason to immediately check capillary blood glucose. All blood glucose checking should be recorded for a minimum of consecutive three days and communicated to health care providers through tele-consultation [2, 7] . Lockdown during COVID-19 pandemic could affect patient's dietary habit. Patients with diabetes may find limited access to fresh fruits and vegetables [2, 7] and consume canned or packaged foods that are high in calories and/or fats [2] . Healthy and balanced diet should be emphasized and encouraged by dietician to diabetic patients during the consultation [7, 13] . The recommended calorie intakes for obese and non-obese diabetes patients are 20 kcal/kg and 22-25 kcal/kg of ideal body weights with sedentary lifestyle, respectively. Dietary advice should include low carbohydrate intake, low fats intake, and optimal protein intake with no meal skipping [13] . Daily diet should be divided into three meals and a snack. Variation of food composition is recommended, consisting of 50-60% complex carbohydrates, 25-45% fibers, up to 30% fats, 1 g/kg/day (general patients) or 0.8 g/kg/day (nephropathy and macro-albuminuria) of proteins. The use of oils should be no more than 3 teaspoons a day and less than 5 g/day for sodium intake. Patients could also use the diabetes plate method i.e. half plate of vegetables, one-fourth of proteins, and one-fourth of complex carbohydrates. Alcohol, smoking, and sugary sweetened foods should be avoided [7] . Social distancing, lockdown and home confinement require patients with diabetes to limit their activities or regular exercise. However, they could still have limited access to indoor and outdoor physical activities [2] . Home exercise such as treadmill, stationary cycling or jogging and resistance training should be recommended [2, 7, 13] . Tailored physical activity while quarantine should be practiced about 60 min/day. The intensity and type of activities could be adjusted regarding individual patient's condition. The recommended physical activity is classified into three exercises i.e. aerobics, flexibility workout, and strength muscle exercises. Aerobic exercise with moderate intensity i.e. brisk walking, treadmill, stationary jogging or cycling, dancing, jumping, sport aerobic, and gardening, is suggested for a minimum of 30 min/day [7, 13] . If this is unachievable, patients could take two or three times in small portion of aerobic exercise (10-15 min). Climbing stairs, household routine activities [7] or yoga practice as stretching technique [13] for 15 min/day is recommended as flexibility training [7, 13] . A 11 steps of yoga pranayama for chronic condition could be implemented to enhance pulmonary function [17] . A 15 min of squats, push-ups, sit-ups, forward flexes or small weight lift as muscle training exercise every day is recommended as muscle training exercises [7, 13] . A physical activity for diabetes patients with heart diseases or hypoglycemia history should be noticed as particular circumstance [7] . Health care providers need to assess patient's adherence to medication through teleconsultation using valid but brief tools. They also should make sure that all diabetes patients have sufficient medication stocks and prescribe enough medication because of limited access to clinic during the pandemic [7] . To date, there is no robust evidence of anti diabetic agents in the context of treatment for COVID-19 patients with diabetes though some anti diabetic agents indicate positive outcome of glycemic control reduction. The application of angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) is hypothetically useful to treat COVID-19 patients, however, there is still no data to support it. Currently, the Association of European and American Cardiology and Hypertension recommend ACE inhibitors and ARB to treat COVID-19 although it lacks of evidence to support [2] . Adjustment of sulfonylurea and insulin dose may be necessary to prevent hypoglycemia. All diabetes patients should be provided information on adverse effects of anti-diabetic agents and encourage them to report any adverse effect [13] . Additionally, it was reported that 44.9% non-ICU and 72.2% ICU patients with COVID-19 received glucocorticoid therapy as daily treatment. Glucocorticoid was associated with hyperglycemia and induced more severe clinical manifestation. Recent review found that the use of glucocorticoid was not recommended to treat COVID-19 pneumonia and could cause harm. Previous reported COVID-19 patients obtained a hydroxychloroquine therapy. In a small-randomized trial, COVID-19 patients with mild sign/symptom of pneumonia (by CT scan), received oral hydroxychloroquine 200 mg twice a day for five days. About 80.6% patients indicated improvement of COVID-19 pneumonia and none developed severe COVID-19 pneumonia. Among COVID-19 patients with diabetes, hydroxychloroquine works as hypoglycemia agent by decreasing HbA1c and hyperglycemia [11] . COVID-19 patients with type 1 diabetes who receive Chloroquine therapy is potentially experiencing hypoglycemia as its side effect. Chloroquine agent has hypoglycemia and immunomodulatory effects, and therefore all patients should be closely monitored. In diabetic animals, Chloroquine causes an increase in the level of insulin serum by providing a signal to cellular receptors and post-receptor clearance [12] . All diabetic patients who receive hydroxychloroquine should obtain education on the contraindication such as diabetic neuropathy and history of seizure [7] . Because of the COVID-19 pandemic, regular visit to hospital/clinic by diabetes is impeded. Type 1-diabetes patients should contact endocrinologists while type 2 diabetes patients are suggested to consult with internal medical specialists or general practitioners [5, 7] . It is recommended to conduct online or tele-consultation to keep in touch with the health care providers [7, 8] . Endocrinologist could provide consultation by optimizing the use of smartphone application (i.e. WeChat, WhatsApps, Line) to share educational videos, ebooks, and recommendations [8] . A previous meta-analysis showed that telemedicine practice during non-pandemic era by emails, phones, and videos, for 3-60 months in China showed significant reduction of HbA1c (-0.37%, p < 0.001) [18] . Another Cochrane review on telemedicine also indicated similar outcomes, i.e. decline in HbA1c of 0.31% (p < 0.001) [19] . A recent review on 46 studies on telemedicine among type 1 (n = 2,052) and 2 diabetes (n = 24,000) patients showed significant reduction of HbA1c (-0.12% to -0.86% and -0.01 to A video mode of telemedicine is also recommended for the first consultation. Patient's privacy, confidentiality, and consent (from surrogates, caregivers or patients) should be maintained. Radiology, laboratory findings and prescription should be integrated in medical records. Previous history of complaint, allergy, and hypoglycemia are of main concern. Identification of any noticeable neurological deficit is applicable by requesting patients to perform simple neurological test. Video or photograph could help when suspecting any lesion on foot, abscess or visible wound. All patients should recognize sign/symptom of hypoglycemia and know how to treat it. Health care providers should always remind patients to do hand washing, cough technique and social distancing as general precaution during teleconsultation. When telemedicine or tele-consultation is not compatible, face-to-face clinic visit is acceptable by considering time and place for preventing transmission of Cavid19. Telemedicine is also not doable for clinical examination and psychotropic/narcotic prescription [13] . As previously reported, patients with diabetes are at higher risk for COVID-19 infection. In general, diabetes patients should adhere to social distancing and home confinement policy as primary preventive method. They should avoid contacts or exposure with confirmed COVID-19 patients as much as they can. It is recommended that patients with diabetes should arrange an individual plan of diabetes management while staying at home or getting sick. They can make to a do list for dietary intakes, physical activities, and stress management during confinement. All diabetes patients are strongly recommended to keep maintaining their glycemic control as part of risk reduction of infection and/or prevent severe consequence of infection for confirmed COVID-19 patients with diabetes [5, 8] . All diabetes patients should visit hospital to consult with physicians or nurses when they are suspected of COVID-19 infection. Fever and cough, dyspnea or pneumonia, visiting a pandemic area and recent contact with confirmed COVID-19 patients are factors for diabetes patients to be suspected as COVID-19 infection. When patients decide to go to hospital or clinic, patients with diabetes should use facemasks. They will undergo diagnosis procedure by taking samples from noses or throat [5] . In case of home confinement, patients and families should adhere to the rules for affected or suspected people because it could help to prevent further transmission to other patients and/or families. The affected people should live in a single room with proper ventilation, meanwhile other family members stay in different room. If this is not applicable, make sure to always keep a minimum one-meter distance from the affected person, routine hand washing after any contact with the affected patient or the environment and use disposable paper towel or clean towel (and replace it when it is getting wet) after hand wash. The affected person should use medical mask to cover nose and mouth. All caregivers also need to wear full-covered medical mask when being in the same room with the affected person [5] . Diabetes management is inevitably altered during the COVID-19 pandemic. Therefore, specific condition is required for specific circumstances. The following section will discuss diabetes management in a certain population or situation based on the current available evidences. In child or adolescent with newly diagnosed type 1 diabetes, it is recommended to take face-to-face mode of consultation. Type 1 diabetes patients and families should visit diabetes clinic to initiate insulin administration. Health care providers should make sure that patients and families receive diabetes education with highlighted topic on insulin administration, hypoglycemia and ketoacidosis sign/symptom and management. For the follow up of type 1diabetes patients, ketoacidosis test should be advised when experiencing hyperglycemia [13] . All patients with gestational diabetes should undergo face-to-face consultation for insulin initiation during their first visit. Patients should obtain tailored education related their diabetes and current condition for lifestyle management. Minor adjustment of insulin dose may be necessitated for follow up gestational diabetes patients using telemedicine/teleconsultation [13] . Elderly patients with diabetes are more likely to have deteriorated glycemic control as result of raised blood glucose amid COVID-19 pandemic [7] . Hyperglycemia or hypoglycemia could occur due to limited access of care during lockdown and quarantine, which stimulate unstable blood glucose. It can lead to further serious complication for elderly patients with diabetes for example ketoacidosis, infection, coma hyperosmolar, and cardiac event. The drawback is more distinct among elder diabetic patients who live alone [2] . It is recommended to encourage them and always keep in touch with health care providers and quickly seek for help when needed. All diabetic patients who are experiencing drowsiness, vomiting, chest pain, short of breath, limb weakness, and altered sensory should be noticed as emergency situation [9] . In addition, diabetic patients with any foot lesion, gangrene, severe hypoglycemia, gastroenteritis, and any other infection related to COVID-19 should be addressed for special condition. All of these situations require hospital/clinic visit or admission [13] . Health care providers should make sure diabetic patients understand about those signs/symptoms and take initial action to hospital/clinical appointment. For confirmed COVID-19 patients with diabetes who receive critical care, intensive blood glucose monitoring should become priority of care. Adverse effect of drug reaction should be early identified [8] . Diabetes has noticed an independent factor of ICU admission and raised risk of mortality rate [3, 7, 11] . It was reported that COVID-19 patients with diabetes comorbidity had twice the risk to be admited ICU and receive critical care [3] . Other study described that COVID-19 patients with diabetes contributed to 22.2% -58% of ICU admission due to septic shock and acute respiratory distress syndrome as result of blood glucose variability and elevated blood pressure [8, 11] . The mortality risk of COVID-19 patients with diabetes is three times higher than non-diabetic patients [3] . Current reports noted the mortality rate of COVID-19 patients with diabetes was 7.3% -7.6% [8, 11] . Thus, all health care providers should more concern when caring COVID-19 patients with diabetes during hospitalization. This is a scoping review to provide broader scope of diabetes management and action for particular consideration. Thus, there was no included level of evidence and quality evaluation. In addition, there was unclear methodological approach among included articles (author(s) did not definitely express the method section). Three included articles did not provide clear information about study design and data collection process. Five out of seven included articles did not specify the sample size and one article used one-sample size (case report). The limitation on the included studies causes a limitation for this scoping review. This review produced a summary of diabetes management and specific considerations amid the COVID-19 pandemic for diabetes patients. Patients and family members could use this review to deal with diabetes management, concern on particular situations of diabetes, and seek for help when needed. Health care providers and policy makers could take concern on review results to facilitate people living with diabetes passing through the COVID-19 pandemic. Samples from nose or throat will be examined as diagnosis procedure. 2. Since regular visit is not recommended, it is suggested to utilize tele-consultation by smartphones to keep in touch with healthcare providers. 3. Required calorie of daily intake for non-obese and obese patients is 22-25 kcal/kg and 20kcal/kg of ideal body weights on sedentary lifestyle, respectively which distributed in three meals and a snack as their habits. Food composition should be maintained 50-60% (complex) carbohydrates, 25-45% fibers, no more than 30% fats, and 1 g/kg/day (general) or 0.8/kg/day (nephropathy and macro-albuminuria) for protein. Three teaspoons of oil/day (combined with 2 or more vegetable oils) and no more than 5 g of sodium in daily. COVID-19 and diabetes: knowledge in progress Diabetes in COVID-19: prevalence, pathophysiology, prognosis and practical considerations Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome Commentary: COVID-19 in patients with diabetes. Metab COVID-19 and endocrine diseases Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China Diabetes self-management amid COVID-19 pandemic Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed Scoping studies: towards a methodological framework Preferred reporting items for systematic review Hydroxychloroquine, and the COVID-19 Epidemic Case report of chloroquine therapy and hypoglycaemia in type 1 diabetes: What should we have in mind during the COVID-19 pandemic? Telemedicine for diabetes care in India during COVID-19 pandemic and national lockdown period: Guidelines for physicians Summary of Revisions: Standards of Medical Care in Diabetesd-2019 Lifestyle Management: Standards of Medical Care in Diabetesd-2019 Diabetes Care in the Hospital: Standards of Medical Care in Diabetes-2019 Effect of yoga on pulmonary function among asthmatic patients: a protocol synthesis Clinical-and cost-effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-analysis Interactive telemedicine: effects on professional practice and health care outcomes. Cochrane Database Syst Rev Mapping the evidence on the effectiveness of telemedicine interventions in diabetes, dyslipidemia, and hypertension: an umbrella review of systematic reviews and meta-analyses The authors declare that there is no conflict of interest.